First Approval for Immunotherapy for Esophageal Cancer
Categories
Esophageal cancer has now joined the list of tumor types that can be treated with immunotherapy, after approval of the immune checkpoint inhibitor pembrolizumab (Keytruda, Merck & Co) for this indication.
https://www.medscape.com/viewarticle/916257
First Approval for Immunotherapy for Esophageal Cancer
Categories
Esophageal cancer has now joined the list of tumor types that can be treated with immunotherapy, after approval of the immune checkpoint inhibitor pembrolizumab (Keytruda, Merck & Co) for this indication.
https://www.medscape.com/viewarticle/916257